Strides Pharma Science said that its stepdown fully-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and Drug Administration (USFDA) for Cyclosporine Softgel Capsules USP (Modified), 25 mg, 50 mg, and 100 mg. The immunosuppressant medication product is bioequivalent and therapeutically equivalent to Neoral Capsules 25 mg, 50 mg, […]
Strides Pharma Science Limited said that its stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and Drug Administration (FDA) for Ibuprofen Oral Suspension USP, 50 mg/1.25 mL (40 mg/mL) (OTC). The pain drug product from Strides Pharma is the generic of GlaxoSmithKline Consumer Healthcare Holdings (US)’s […]
Strides Pharma Science Limited said that its Singapore-based stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited has secured approval for Colchicine Tablets USP, 0.6 mg from the US Food & Drug Administration (USFDA). Colchicine Tablets USP, 0.6 mg is bioequivalent and therapeutically equivalent to Colcrys Tablets, 0.6 mg, of Takeda Pharmaceuticals U.S.A. Colchicine tablets […]
Strides Pharma Science Limited said that Strides Pharma Global Pte. Limited, Singapore, its step-down fully-owned subsidiary, has secured approval for Oseltamivir Phosphate for Oral Suspension,6 mg/mL from the US Food & Drug Administration (FDA). The drug is bioequivalent and therapeutically equivalent to Tamiflu for Oral Suspension, 6 mg/mL, of Hoffmann-La Roche (Roche). As per IQVIA […]
Strides Pharma Science Limited will acquire the manufacturing facility of Endo International in Chestnut Ridge, New York along with a portfolio of abbreviated new drug applications (ANDAs) for nearly $24 million. The Indian pharma company said that the deal will help it further strengthen its footprint in the US, courtesy of the multi dosage facility […]
Stelis Biopharma Limited, a biopharma and vaccines company and the biotech arm of Strides Pharma Science has appointed Mark W. Womack as its new chief executive officer (CEO). Mark W. Womack is also the designated managing director and will be inducted to the board of directors later depending on the required statutory clearances and processes. […]